Based on the results of our data collection, we found that weight-based dosing with enoxaparin 0.5 mg/kg in morbidly obese, critically ill patients was effective in achieving anti-factor Xa levels ...

RESULTS: A weight-based dosage range of enoxaparin 50 ... The mean BMI was 46.4 kg/m2. The initial mean anti-factor Xa level (measured after the third dose) was 0.34 IU/mL (range 0.20–0. ...

Amphastar Pharmaceuticals posted modest earnings growth but fell short of market expectations in its latest quarterly results ...

Adjusted EPS grew to $0.92, a 4.5% rise over the previous year ... Epinephrine sales fell by 24% due to heightened competition, and Enoxaparin revenues dropped 39% amid market shifts.

Smartleaf Asset Management LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 222 ...

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) hit a new 52-week low during mid-day trading on Friday . The company traded as low as $29.27 and last traded at $28.46, with a volume of ...

While the mutation was linked to these miscarriages, results found that administering folic acid alongside low dose aspirin and enoxaparin was ... contains at least 0.4 milligrams (mg) of folic ...

For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 ...

The Jordan 4 has been arguably the hottest retro design from the iconic brand in 2025. With the release of the Abundance and ...